EGFR and non-small cell lung carcinoma: Together, these mutations are reported to account for  ̃1.5% of rare EGFR mutations in NSCLC, although the actual frequency of E709X and exon 18 deletions may be underreported as they are not detectable by many common commercially available diagnostic kits [35,36].